170 related articles for article (PubMed ID: 37792048)
21. Enhanced cAMP response of naturally occurring mutant of human beta3-adrenergic receptor.
Isogaya M; Nagao T; Kurose H
Jpn J Pharmacol; 2002 Mar; 88(3):314-8. PubMed ID: 11949887
[TBL] [Abstract][Full Text] [Related]
22. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.
Hicks A; McCafferty GP; Riedel E; Aiyar N; Pullen M; Evans C; Luce TD; Coatney RW; Rivera GC; Westfall TD; Hieble JP
J Pharmacol Exp Ther; 2007 Oct; 323(1):202-9. PubMed ID: 17626794
[TBL] [Abstract][Full Text] [Related]
23. Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor.
Blin N; Nahmias C; Drumare MF; Strosberg AD
Br J Pharmacol; 1994 Jul; 112(3):911-9. PubMed ID: 7921620
[TBL] [Abstract][Full Text] [Related]
24. Functional coupling of beta3-adrenoceptors and large conductance calcium-activated potassium channels in human uterine myocytes.
Doheny HC; Lynch CM; Smith TJ; Morrison JJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5786-96. PubMed ID: 16014404
[TBL] [Abstract][Full Text] [Related]
25. Human β3-Adrenoreceptor is Resistant to Agonist-Induced Desensitization in Renal Epithelial Cells.
Milano S; Gerbino A; Schena G; Carmosino M; Svelto M; Procino G
Cell Physiol Biochem; 2018; 48(2):847-862. PubMed ID: 30032151
[TBL] [Abstract][Full Text] [Related]
26. Anti-obesity and anti-diabetic activities of a new beta3 adrenergic receptor agonist, (S)-(Z)-[4-[[1-[2-[(2-hydroxy-3-phenoxypropyl)]amino]ethyl]-1-propenyl] phenoxy] acetic acid ethanedioic acid (SWR-0342SA), in KK-Ay mice.
Kiso T; Namikawa T; Tokunaga T; Sawada K; Kakita T; Shogaki T; Ohtsubo Y
Biol Pharm Bull; 1999 Oct; 22(10):1073-8. PubMed ID: 10549858
[TBL] [Abstract][Full Text] [Related]
27. CNS β
Richard JE; López-Ferreras L; Chanclón B; Eerola K; Micallef P; Skibicka KP; Wernstedt Asterholm I
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E344-E358. PubMed ID: 28588096
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of pharmacological properties of T-0509 for beta-adrenoceptors.
Sato Y; Kurose H; Isogaya M; Nagao T
Eur J Pharmacol; 1996 Nov; 315(3):363-7. PubMed ID: 8982677
[TBL] [Abstract][Full Text] [Related]
29. Expression and functional role of β3 -adrenoceptors in the human ureter.
Matsumoto R; Otsuka A; Suzuki T; Shinbo H; Mizuno T; Kurita Y; Mugiya S; Ozono S
Int J Urol; 2013 Oct; 20(10):1007-14. PubMed ID: 23360304
[TBL] [Abstract][Full Text] [Related]
30. Characterization of mexiletine as an antagonist of beta-adrenoceptor in Chinese hamster ovary cells expressing cloned human beta-adrenoceptors.
Sakamoto K; Karikomi Y; Kubota Y; Nakahara T; Ishii K
Biochem Pharmacol; 2004 Mar; 67(5):815-22. PubMed ID: 15104234
[TBL] [Abstract][Full Text] [Related]
31. Functional effects of β3-adrenoceptor on pacemaker activity in interstitial cells of Cajal from the mouse colon.
Wu MJ; Shin DH; Kim MY; Park CG; Kim YD; Lee J; Park IK; Choi S; So I; Park JS; Jun JY
Eur J Pharmacol; 2015 May; 754():32-40. PubMed ID: 25725113
[TBL] [Abstract][Full Text] [Related]
32. Dependence of β3-adrenergic signaling on the adipokine leptin in cardiac myocytes.
Larson JE; Rainer PP; Watts VL; Yang R; Miller KL; Phan A; Barouch LA
Int J Obes (Lond); 2012 Jun; 36(6):876-9. PubMed ID: 21772246
[TBL] [Abstract][Full Text] [Related]
33. The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors.
Baker JG
Br J Pharmacol; 2010 Jul; 160(5):1048-61. PubMed ID: 20590599
[TBL] [Abstract][Full Text] [Related]
34. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
35. Stereoselectivity for interactions of agonists and antagonists at mouse, rat and human beta3-adrenoceptors.
Popp BD; Hutchinson DS; Evans BA; Summers RJ
Eur J Pharmacol; 2004 Jan; 484(2-3):323-31. PubMed ID: 14744619
[TBL] [Abstract][Full Text] [Related]
36. A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptors.
Baker JG
PLoS One; 2010 Nov; 5(11):e15487. PubMed ID: 21152092
[TBL] [Abstract][Full Text] [Related]
37. Evidence for beta3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods.
Takeda M; Obara K; Mizusawa T; Tomita Y; Arai K; Tsutsui T; Hatano A; Takahashi K; Nomura S
J Pharmacol Exp Ther; 1999 Mar; 288(3):1367-73. PubMed ID: 10027879
[TBL] [Abstract][Full Text] [Related]
38. Vibegron shows high selectivity and potent agonist activity for β3-adrenoceptors, irrespective of receptor density.
Yamamoto S; Kusabuka H; Matsuzawa A; Maruyama I; Yamazaki T
PLoS One; 2023; 18(9):e0290685. PubMed ID: 37656760
[TBL] [Abstract][Full Text] [Related]
39. Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension.
García-Álvarez A; Pereda D; García-Lunar I; Sanz-Rosa D; Fernández-Jiménez R; García-Prieto J; Nuño-Ayala M; Sierra F; Santiago E; Sandoval E; Campelos P; Agüero J; Pizarro G; Peinado VI; Fernández-Friera L; García-Ruiz JM; Barberá JA; Castellá M; Sabaté M; Fuster V; Ibañez B
Basic Res Cardiol; 2016 Jul; 111(4):49. PubMed ID: 27328822
[TBL] [Abstract][Full Text] [Related]
40. L-750355, a human beta3-adrenoceptor agonist; in vitro pharmacology and profile of activity in vivo in the rhesus monkey.
Forrest MJ; Hom G; Bach T; Candelore MR; Cascieri MA; Strader C; Tota L; Fisher MH; Szumiloski J; Ok HO; Weber AE; Wyvratt M; Vicario P; Marko O; Deng L; Cioffe C; Hegarty-Friscino B; MacIntyre E
Eur J Pharmacol; 2000 Oct; 407(1-2):175-81. PubMed ID: 11050305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
